Product theaters - Room 116

Monday, 2 July 2018

11:45 – 12:45 ► Irvine Scientific
“Improve IVF Results: How Do New Technologies Play a Role?” - Download announcement here
Chairman: Dr. Richard Rawlins, PhD, HCLD

  • Stress relief: Continuous culture in a low lactate media improves euploid rates│Dr Matthew “Tex” VerMilyea, Lab Director, Ovation Fertility USA
  • 100% survival rates after blastocyst biopsy using Irvine Scientific vitrification system│Dr Jorge Ten, Lab Director, Instituto Bernabeu



14:00 – 15:00 ► Vitrolife Sweden - Download announcement here
“How to optimise the efficiency and outcomes of your IVF procedures”
Chairman: Dr Mark Larman, CSO, Vitrolife

  • Improve the oocyte retrieval procedure for you and your patient│Dr Andrew Kan M.D., Senior Fertility Clinician, Foundation Doctor at IVF Australia, Australia
  • Protecting the embryo to ensure maximum developmental potential│Prof. David K. Gardner, FAA, University of Melbourne, Scientific Director, Melbourne IVF, Australia
  • Reduce your mosaic embryos by optimising your laboratory conditions│Dr Mandy Katz-Jaffe, Ph.D, Scientific and Genetics Director, Colorado Center for Reproductive, USA



17:00 – 18:00 ► Alfasigma Healthscience
“Clinical evidence supporting the use of Nutraceutical formulations in the treatment of male and female factor infertility”
Chairmen: Professor Ashok Agrawal and Dr Jonathan Ramsay

17.00-17.25 Improving sperm function and male fertility using a specific micronutrients combination│Prof Gian Maria Busetto
17.25-17.30 Questions & Answers
17.30-17.55 Improving the chances of pregnancy by addressing hormonal and metabolic alterations│Prof. Alessandro Genazzani
17.55-18.00 Questions & Answers

 

Wednesday, 4 July 2018

08:30 – 09:30 ► Guerbet 
“Lipiodol HSG: the therapeutic effects of a diagnostic HSG- Emerging data”
Chair: Antoine Watrelot, France│Co-chair: Velja Mijatovic, The Netherlands

  • Infertility workup- HSG is not dead, back to the future│Antoine Watrelot, France
  • HGS with Lipiodol practice│Velja Mijatovic, The Netherlands
  • Lipiodol Uterine Bathing or Tubal Flushing - Overview of Evidence up to 2018│Neil Johnson, New Zealand
  • Therapeutic effect of oil-based- versus water-based contrast for hysterosalpingography (HSG) during the fertility work-up│Ben Mol, Australia


12:00 – 13:00 ► Lo.Li. Pharma International - Download announcement here
Inositols for him and for her: from pre-clinical to clinical
Main Chairman: Professor Nicolàs Mendoza (Spain)
Second Chairman: Professor Arturo Bevilacqua from the University of Rome

  • Treatment with myo-inositol and D-chiro-inositol (40:1) successfully reverses polycystic ovary syndrome in an experimental mouse model (about preclinical new studies on the use of Myo-inositol and D-Chiro-Inositol in mouse models) │ Professor Mariano Bizzarri - Eminent oncologist and researcher at the university of Rome
  • Therapeutic roles of Inositol stereoisomers in the physiopathology of PCOS and related infertility (about the use of inositols in the management of PCOS and related fertility) │ Professor Zdravko Kamenov - Endocrinologist at the University of Sofia
  • Therapeutic roles of Inositol in the management of oligoasthenoteratozoospermia (about the use of Inositols in male infertility) │ Professor Aldo Calogero - Professor of Andrology at the University of Catania

 


Product Theatres – Room 129

Monday, 2 July 2018


09:15 – 10:15 ► Thermo Fisher Scientific and Technology intro:

  • Reproductive healthcare: analytical performance of a high-throughput genotyping approach for comprehensive preconception carrier screening – Julio Martín (Igenomix)
  • Embryo aneuploidy testing by NGS - Carmen Rubio (Igenomix)
  • Improving PGT through PGD-Seq and Ion Reproseq PGS Kit - Luis Alcaraz (Bioarray)


10:30 – 11:30 ► ObsEva
Nolasiban – A New Oral Oxytocin Receptor Antagonist to Increase Live Birth Rates Following Fresh Embryo Transfer Resulting from In Vitro Fertilization (IVF)
Chair: Ben Willem Mol│Co-chair: Ernest Loumaye

  • Oxytocin Receptor Antagonists and Uterine Receptivity: Physiological Background and Potential Mechanism of Action│Speaker: Lan N. Vuong, MD, PhD - University of Medicine and Pharmacy at Ho Chi Minh City, Viet Nam 
  • Clinical Evidence for Nolasiban to Increase Pregnancy and Live Birth Rates: Results of Two Large Placebo Controlled Randomized Trials│Speaker: Christophe Blockeel, MD, PhD - Centre for Reproductive Medicine, Free University of Brussels, Belgium
  • Nolasiban as a Catalyst for Elective Single Embryo Transfer (eSET)│Speaker: Ben Willem Mol, FRANZCOG, PhD - Department of Obstetrics and Gynaecology, Monash University, Australia
  • Conclusions - Q&A



17:45 – 18:45 ► Aytu BioScience - Download announcement here
“Male Infertility: Understanding the Role and Implications of Oxidative Stress”
Speakers:

  • Ashok Agarwal, Ph.D.
    Professor of Surgery (Urology), Director of Andrology Center. Lerner College of Medicine, Case Western Reserve University and Cleveland Clinic
  • Moncef Benkhalifa, Ph.D.
    Clinical Embryologist & Professor of Medicine. Picardie University. Jules Verne. France

 

Tuesday, 3 July 2018


08:30 – 09:30 ► Beckman Coulter
“A Data-Driven Approach to Patient-Centered Care. How to implement AMH effectively in clinical practice”
Intro:
This event will cover in detail information on:

  • Age stratified AMH in PCOS
  • U.S. multisite-study updates: Defining poor ovarian reserve
  • Consistent patient results with automated AMH testing


Presented by:

  • Dr. Michael Alper, MD
    Medical Director, Boston IVF, Associate Clinical Professor of ObGyn, Harvard Medical School
  • Professor Roy Homburg, MB.BS, FRCOG
    Head of Research, Homerton Fertility Centre, Homerton University Hospital, London, UK
  • Lindsay Sun, MD, MS
    Beckman Coulter Scientific Medical Affairs



09:45 – 10:45 ► ObsEva
Nolasiban – A New Oral Oxytocin Receptor Antagonist to Increase Live Birth Rates Following Fresh Embryo Transfer Resulting from In Vitro Fertilization (IVF)
Chair: Ben Willem Mol│Co-chair: Ernest Loumaye

  • Oxytocin Receptor Antagonists and Uterine Receptivity: Physiological Background and Potential Mechanism of Action│Speaker: Lan N. Vuong, MD, PhD - University of Medicine and Pharmacy at Ho Chi Minh City, Viet Nam
  • Clinical Evidence for Nolasiban to Increase Pregnancy and Live Birth Rates: Results of Two Large Placebo Controlled Randomized Trials│Speaker: Christophe Blockeel, MD, PhD - Centre for Reproductive Medicine, Free University of Brussels, Belgium
  • Nolasiban as a Catalyst for Elective Single Embryo Transfer (eSET)│Speaker: Ben Willem Mol, FRANZCOG, PhD - Department of Obstetrics and Gynaecology, Monash University, Australia
  • Conclusions - Q&A


11:00 – 12:00 ► Thermo Fisher Scientific and Technology - one step further in at looking at our technologies:

  • Analysis of mosaicism and small segmental aneuploidies in Preimplantation Genetic Testing setting - Francesca Spinella (Laboratorio Genoma)
  • Simultaneous Detection of Chromosomal Aneuploidy and A Monogenic Disease by Next Generation Sequencing with Linkage Analysis - Murat Cetinkaya (Istanbul Memorial Hospital.)


17:45 – 18:45 ► Aytu BioScience - Download announcement here
“Male Infertility: Understanding the Role and Implications of Oxidative Stress”
Speakers:

  • Ashok Agarwal, Ph.D.
    Professor of Surgery (Urology), Director of Andrology Center. Lerner College of Medicine, Case Western Reserve University and Cleveland Clinic
  • Moncef Benkhalifa, Ph.D.
    Clinical Embryologist & Professor of Medicine. Picardie University. Jules Verne. France

 

Wednesday, 4 July 2018


11:00 – 12:00 ► SpOvum Technologies

11:00 - 11.30: Introducing the novel device—RoboICSI by the cofounders of SpOvum Technologies Private Limited --Dr Santosh Bhargav (PhD) and Dr Ramnath Babu T J (PhD)
11:30 - 11:45: Soft-demo and interaction
11:45 - 12:00: Q&A